Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000424912 | SCV000521931 | likely benign | not specified | 2015-12-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000863158 | SCV001003764 | likely benign | not provided | 2024-04-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000424912 | SCV002755218 | likely benign | not specified | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002506034 | SCV002801197 | likely benign | Medulloblastoma; Familial dysautonomia | 2022-04-27 | criteria provided, single submitter | clinical testing |